In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about PCOS, the push to rename it PMOS, and why diagnostic delays so often begin in adolescence.
|Articles|September 4, 2014
Postmenopausal status ups odds of malignant endometrial polyps (VIDEO)
Mary Leuchars, MD, discusses the higher prevalence of malignant or pre-malignant polyps in women undergoing recession of indometrial polyps, who are also post-menopausal and who have abnormal uterine bleeding, as reported in the journal Obstetrics & Gynecology.
Advertisement
Mary Leuchars, MD, discusses the higher prevalence of malignant or pre-malignant polyps in women undergoing recession of indometrial polyps, who are also post-menopausal and who have abnormal uterine bleeding, as reported in the journal
This video is part of the
Video provided by:
Advertisement
Related to this article
A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
A global consensus published in The Lancet has officially renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, a change with broad implications for diagnosis, care, and cardiometabolic screening.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
ACOG issued its most comprehensive menopause guidance, grading treatments for VMS, sleep, and mood symptoms.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Advertisement
Advertisement